New appointment at DxS
This article was originally published in Scrip
Dave Clennell has joined the personalised medicine company DxS (UK) as director of quality. He has worked in quality within the healthcare industry for 30 years, having previously served as international director of quality at Lombard Medical Technologies.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.